These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 12391902)
21. Infections in child-care facilities and schools. Mink CM; Yeh S Pediatr Rev; 2009 Jul; 30(7):259-69. PubMed ID: 19570924 [No Abstract] [Full Text] [Related]
22. An overview of gastrointestinal infections. Lowe S Nurs Stand; 2002 Aug; 16(49):47-52; quiz 54-5. PubMed ID: 12242848 [TBL] [Abstract][Full Text] [Related]
23. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents. Guarner J; Zaki SR J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309 [TBL] [Abstract][Full Text] [Related]
24. Recognition and management of bioterrorism infections. O'Brien KK; Higdon ML; Halverson JJ Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654 [TBL] [Abstract][Full Text] [Related]
25. Threats in bioterrorism. I: CDC category A agents. Darling RG; Catlett CL; Huebner KD; Jarrett DG Emerg Med Clin North Am; 2002 May; 20(2):273-309. PubMed ID: 12120480 [TBL] [Abstract][Full Text] [Related]
26. [From emergent viruses to resistant bacteria, a sanitary crisis and its effects]. Keck F Med Sci (Paris); 2012 May; 28(5):543-6. PubMed ID: 22643010 [No Abstract] [Full Text] [Related]
31. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Fine A; Layton M Clin Infect Dis; 2001 Jan; 32(2):277-82. PubMed ID: 11170918 [TBL] [Abstract][Full Text] [Related]
32. [Emerging or re-emerging infections that can be used for bioterrorism]. Bossi P; Guihot A; Bricaire F Presse Med; 2005 Jan; 34(2 Pt 2):149-55. PubMed ID: 15687965 [TBL] [Abstract][Full Text] [Related]
34. Future challenges in preparing for and responding to bioterrorism events. Jones J; Terndrup TE; Franz DR; Eitzen EM Emerg Med Clin North Am; 2002 May; 20(2):501-24. PubMed ID: 12120489 [TBL] [Abstract][Full Text] [Related]
35. Threats in bioterrorism. II: CDC category B and C agents. Moran GJ Emerg Med Clin North Am; 2002 May; 20(2):311-30. PubMed ID: 12120481 [TBL] [Abstract][Full Text] [Related]
36. Bioterrorism: relevance to allergy and immunology in clinical practice. Fritz SB; Singer AM; Revan VB; Baker JR J Allergy Clin Immunol; 2002 Feb; 109(2):214-28. PubMed ID: 11842289 [TBL] [Abstract][Full Text] [Related]
37. Microbiological threats to homeland security. Yadav P; Blaine L IEEE Eng Med Biol Mag; 2004; 23(1):136-41. PubMed ID: 15154270 [No Abstract] [Full Text] [Related]
38. Vaccines for the prevention of diseases caused by potential bioweapons. Hassani M; Patel MC; Pirofski LA Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546 [TBL] [Abstract][Full Text] [Related]